Back to search

University of Nevada, Reno

The Role of Galectin-1 in Duchenne Muscular Dystrophy Disease Progression

Abstract

dc:description.abstract

Duchenne Muscular Dystrophy (DMD) is a genetic disorder caused by mutations in the dystrophin gene and affects 1 out of 5,000 male children (Heller et al.). Patients who are diagnosed with this life-threatening disease usually suffer from respiratory failure due to irreversible effects on the diaphragm resulting in premature death. Mdx mice have the same dysfunctional dystrophin gene as patients and are the standard mouse model used for DMD. No cure for this devastating disease exists. The Burkin Lab at the University of Nevada, Reno has shown that mdx mice treated with recombinant Galectin-1 protein exhibit improved skeletal muscle viability and pathology. However, the mechanisms of these improvements have yet to be elucidated. This study has provided evidence that Galectin-1 plays a role in the mechanism and pathology of DMD for potential uses as a protein treatment therapy in patients afflicted with the disease.

Degree

thesis:*
Name thesis:degree_name
Biology
Level thesis:degree_level
Honors Thesis
Department thesis:degree_department
Biology
Grantor
University of Nevada, Reno
Year dc:date.issued
2016

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Tice, Jordan
Advisor dc:contributor.advisor
  • Burkin, Dean J.

Rights

dc:rights
Statement dc:rights
  • In Copyright
  • Author(s)
Language dc:language.iso
en_US, English

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/11714/3328

Chain of custody

source
Harvested from
University of Nevada - Reno
Base URL
scholarwolf.unr.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Tice, Jordan. The Role of Galectin-1 in Duchenne Muscular Dystrophy Disease Progression. Honors Thesis thesis, University of Nevada, Reno, 2016. http://hdl.handle.net/11714/3328